RSV

The respiratory syncytial virus (RSV), which results in tens of thousands of hospital admissions and fatalities each year, has finally received approval from European regulatory authorities. The Arexvy injection, manufactured by British pharmaceutical company GSK (GSK.L), is intended to safeguard individuals 60 and older. RSV normally manifests as cold-like symptoms, but in young children and … Read more